Inogen Inc (INGN) Fundamentals

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
SHARE INFORMATION
Market Cap$ 603,550,035
Shares Outstanding22,835,794
Float10,559,031
Percent Float46.24%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 358,003,000
Latest Fiscal EPS$ -0.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions456
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months4,021,759
Institutional Holdings Percent96.6%
Institutional Sold Previous 3 Months1,727,209
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months383,569
Insider Holdings Percent1.4
Insider Sold Previous 3 Months45,733
Insider Shares Owned316,171
TRADING INFO
52 Week High$ 82.35
52 Week Low$ 22.51
52 Week High Change$ -61.57
21 Day Moving Average$ 25.4567
21 Day Extended Moving Average$ 25.3345
50 Day Moving Average$ 25.7972
50 Day Extended Moving Average$ 26.397
200 Day Moving Average$ 33.0629
200 Day Extended Moving Average$ 33.9153
10 Day Average Volume167,946
20 Day Average Volume150,674
30 Day Average Volume161,040
50 Day Average Volume181,450
Alpha-0.016340
Beta1.0035
Standard Deviation0.168578
R20.079465
7 Day Price Change$ 2.67
7 Day Percent Change11.24%
21 Day Price Change$ -0.15
21 Day Percent Change-0.56%
30 Day Price Change$ 0.59
30 Day Percent Change2.28%
Month to Date Price Change$ 0.75
Month to Date Percent Change2.92%
Quarter to Date Price Change$ -5.99
Quarter to Date Percent Change-18.48%
180 Day Price Change$ -6.22
180 Day Percent Change-19.05%
200 Day Price Change$ -4.38
200 Day Percent Change-14.22%
Year to Date Price Change$ -7.57
Year to Date Percent Change-22.26%

Inogen Inc (INGN) Key Ratios

PROFITABILITY
EBIT Margin-0.6%
EBITDA Margin5.7%
Pre-Tax Profit Margin3.8%
Profit Margin Count-5.76%
Gross Margin48.8%
Profit Margin TOT-5.76%
INCOME STATEMENTS
Revenue$ 351,456,000
Revenue Per Share$ 15.3906
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.20
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio5.30
Leverage Ratio1.30
Quick Ratio4.30
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-28.60
Enterprise Value$ 377,427,292
Price to Sales1.7173
Price to Free Cash-28.30
PE High Last 5 Years302.90
Price To Book1.60
Price To Cash Flow213.00
PE Low Last 5 Years-108.40
Price to Tangible Book2.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.70
Invoice Turnover6.10
Assets Turnover0.80
Return Assets-4.29
Return on Equity-5.70
Return on Capital-5.24

Inogen Inc (INGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEONabil Shabshab
Emplyoees1021
Last AuditUQ
CIK0001294133
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address301 Coromar Drive
Goleta, CA 93117
Websitehttps://www.inogen.com
Facsimile-
Telephone+1 805 562-0500
Emailmbacso@inogen.net


Your Recent History
NASDAQ
INGN
Inogen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.